Stephen Smolinski

Chief Commercial Officer, Selecta Biosciences (United States).

Companies

Avalo Therapeutics, Inc.Chief Commercial Officer Jan 6, 2022 to Jan 6, 2022¹
Selecta Biosciences (United States)Chief Commercial Officer Oct 27, 2017 to Jan 6, 2020²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAvalo Therapeutics, Inc., Chief Commercial Officer
2
SEC EDGARSelecta Biosciences (United States), Chief Commercial Officer